Depymed Received $100k from Accelerate Long Island & LIETF

DepYmed, a joint venture of Cold Spring Harbor Laboratory and New York City-based biotech Ohr Pharmaceutical led by Andreas Grill, has received $100,000 from Accelerate Long Island and the Long Island Emerging Technologies Fund. Andreas Grill has served as a BioEntrepreneur-in-Residence for the center for Biotechnology and DepYmed is developing a new drug called Trodusquemine that it hopes will one day treat HER2-positive breast cancer, an aggressive form of the disease. Read more about the company and the investment from Accelerate and LIETF here.

Life Sciences Summit 2014: October 28-29, NYC

The Life Sciences Summit is an early stage investor and business development conference that highlights innovation. The objective of the event is to connect biotech and academic innovators with the capital and strategic partners they will need to move new discoveries into clinical development. This year’s event will take place on October 28-29 at 10 on the Park at Time Warner Center in New York City. Visit www.lifesciencessummit.org for full event details.

$500k in Funding For Biotech Startups Announced

The Accelerate Long Island (ALI) Seed Fund and the Long Island Emerging Technologies Fund (LIETF) announced initial investments in five Long Island-based biotech and clean energy startups. Four of the five companies each receiving $100,000 are CFB Client companies: Goddard Labs, PolyNova, SynchroPET and Traverse Biosciences. Read the full press release here.